BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1503 related articles for article (PubMed ID: 25928283)

  • 21. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
    Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
    Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
    Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
    JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services.
    Hoey SE; Devereux CE; Murray L; Catney D; Gavin A; Kumar S; Donnelly D; Dolan OM
    Br J Dermatol; 2007 Jun; 156(6):1301-7. PubMed ID: 17535230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
    Lewis KG; Weinstock MA
    Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anatomic Locations of Procedurally Treated Keratinocyte Carcinomas in the US Medicare Population.
    Navsaria LJ; Li Y; Tripathy S; Cox ML; Hinkston CL; Margolis DJ; Wehner MR
    JAMA Dermatol; 2023 Jun; 159(6):643-647. PubMed ID: 37074701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The burden of non-melanoma skin cancers in Auckland, New Zealand.
    Pondicherry A; Martin R; Meredith I; Rolfe J; Emanuel P; Elwood M
    Australas J Dermatol; 2018 Aug; 59(3):210-213. PubMed ID: 29350397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect?
    Staples M; Marks R; Giles G
    Int J Cancer; 1998 Oct; 78(2):144-8. PubMed ID: 9754642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis.
    Amari W; Zeringue AL; McDonald JR; Caplan L; Eisen SA; Ranganathan P
    Rheumatology (Oxford); 2011 Aug; 50(8):1431-9. PubMed ID: 21415022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.
    Frieling UM; Schaumberg DA; Kupper TS; Muntwyler J; Hennekens CH
    Arch Dermatol; 2000 Feb; 136(2):179-84. PubMed ID: 10677093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An ecological study of skin biopsies and skin cancer treatment procedures in the United States Medicare population, 2000 to 2015.
    Wang DM; Morgan FC; Besaw RJ; Schmults CD
    J Am Acad Dermatol; 2018 Jan; 78(1):47-53. PubMed ID: 28947293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
    J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin Cancers in Medicare Beneficiaries With Actinic Keratoses.
    Mohr C; Li Y; Navsaria LJ; Hinkston CL; Shete SS; Margolis DJ; Wehner MR
    JAMA Dermatol; 2023 Dec; 159(12):1368-1372. PubMed ID: 37938822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of nonmelanoma skin cancer.
    Strom SS; Yamamura Y
    Clin Plast Surg; 1997 Oct; 24(4):627-36. PubMed ID: 9342506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995.
    Plesko I; Severi G; Obsitníková A; Boyle P
    Neoplasma; 2000; 47(3):137-42. PubMed ID: 11043834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995.
    Hannuksela-Svahn A; Pukkala E; Karvonen J
    Arch Dermatol; 1999 Jul; 135(7):781-6. PubMed ID: 10411152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report.
    Chuang TY; Reizner GT; Elpern DJ; Stone JL; Farmer ER
    J Am Acad Dermatol; 1995 Sep; 33(3):422-6. PubMed ID: 7657865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonmelanoma skin cancer in an Irish population: an appraisal of risk factors.
    Healy E; Collins P; Barnes L
    Ir Med J; 1995; 88(2):58-9. PubMed ID: 7775148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years.
    Christenson LJ; Borrowman TA; Vachon CM; Tollefson MM; Otley CC; Weaver AL; Roenigk RK
    JAMA; 2005 Aug; 294(6):681-90. PubMed ID: 16091570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: A retrospective cohort study.
    Goldenberg G; Karagiannis T; Palmer JB; Lotya J; O'Neill C; Kisa R; Herrera V; Siegel DM
    J Am Acad Dermatol; 2016 Nov; 75(5):957-966.e2. PubMed ID: 27473450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UV dose determines key characteristics of nonmelanoma skin cancer.
    Ramos J; Villa J; Ruiz A; Armstrong R; Matta J
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2006-11. PubMed ID: 15598755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 76.